Patents by Inventor M. N. Tulu Buber

M. N. Tulu Buber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8193168
    Abstract: The present invention is directed to methods of enhancing insulin release, GLP-1 release, and insulin sensitivity, methods of increasing insulin gene expression, methods of decreasing gastric secretion and emptying and glucagons secretion, and methods of inhibiting food intake, and methods of treating diabetes mellitus, insulin resistance syndrome, hyperglycemia, and obesity comprising administering to a subject an effective amount of a TRPM5 inhibitor.
    Type: Grant
    Filed: February 4, 2008
    Date of Patent: June 5, 2012
    Assignee: Redpoint Bio Corporation
    Inventors: S. Paul Lee, Peihong Zhou, M. N. Tulu Buber, Rok Cerne, Robert Bryant, F. Raymond Salemme, Gillian Morgan
  • Patent number: 7875452
    Abstract: There exists a need in the art for high throughput screening assays that can identify compounds that specifically modulate the activity of fast-acting ion channels, such as TRPM5. Current methods, especially electrophysiological, suffer from a lack of sensitivity, rapid signal loss, low throughput, and are labor intensive. The claimed methods and compositions provide electrophysiology methods that allow prolonged sample testing and fluorescent assays with an optical readout that gives rapid readout of the results, has a high signal to noise background ratio, are easy to use, can be modified for automation and miniaturization, and provide verification that a compound specifically modulates TRPM5.
    Type: Grant
    Filed: September 30, 2008
    Date of Patent: January 25, 2011
    Assignee: Redpoint Bio Corporation
    Inventors: Robert W. Bryant, S. Paul Lee, Rok Cerne, M. N. Tulu Buber, Ivona Bakaj, Roy Kyle Palmer
  • Publication number: 20100248988
    Abstract: There exists a need in the art for high throughput screening assays that can identify compounds that specifically modulate the activity of fast-acting ion channels, such as TRPM5. Current methods suffer from a lack of sensitivity, low throughput, and are labor intensive. The claimed methods provide fluorescent assays with an optical readout that gives rapid readout of the results, has a high signal to noise background ratio, are easy to use, can be modified for automation and miniaturization, and provide verification that a compound specifically modulates TRPM5.
    Type: Application
    Filed: May 28, 2010
    Publication date: September 30, 2010
    Applicant: Redpoint Bio Corporation
    Inventors: Robert W. BRYANT, S. Paul Lee, R. Kyle Palmer, Qifeng Yang, M.N. Tulu Buber
  • Patent number: 7749730
    Abstract: There exists a need in the art for high throughput screening assays that can identify compounds that specifically modulate the activity of fast-acting ion channels, such as TRPM5. Current methods suffer from a lack of sensitivity, low throughput, and are labor intensive. The claimed methods provide fluorescent assays with an optical readout that gives rapid readout of the results, has a high signal to noise background ratio, are easy to use, can be modified for automation and miniaturization, and provide verification that a compound specifically modulates TRPM5.
    Type: Grant
    Filed: November 3, 2006
    Date of Patent: July 6, 2010
    Assignee: Redpoint Bio Corporation
    Inventors: Robert W. Bryant, S. Paul Lee, R. Kyle Palmer, Qifeng Yang, M. N. Tulu Buber
  • Publication number: 20090136975
    Abstract: There exists a need in the art for high throughput screening assays that can identify compounds that specifically modulate the activity of fast-acting ion channels, such as TRPM5. Current methods, especially electrophysiological, suffer from a lack of sensitivity, rapid signal loss, low throughput, and are labor intensive. The claimed methods and compositions provide electrophysiology methods that allow prolonged sample testing and fluorescent assays with an optical readout that gives rapid readout of the results, has a high signal to noise background ratio, are easy to use, can be modified for automation and miniaturization, and provide verification that a compound specifically modulates TRPM5.
    Type: Application
    Filed: September 30, 2008
    Publication date: May 28, 2009
    Inventors: Robert W. Bryant, S. Paul Lee, Rok Cerne, M.N. Tulu Buber, Ivona Bakaj, Kyle Palmer
  • Publication number: 20080306030
    Abstract: The present invention is directed to methods of enhancing insulin release, GLP-1 release, and insulin sensitivity, methods of increasing insulin gene expression, methods of decreasing gastric secretion and emptying and glucagons secretion, and methods of inhibiting food intake, and methods of treating diabetes mellitus, insulin resistance syndrome, hyperglycemia, and obesity comprising administering to a subject an effective amount of a TRPM5 inhibitor.
    Type: Application
    Filed: February 4, 2008
    Publication date: December 11, 2008
    Applicant: Redpoint Bio Corporation
    Inventors: S. Paul Lee, Peihong Zhou, M.N. Tulu Buber, Rok Cerne, Robert Bryant, F. Raymond Salemme, Gillian Morgan
  • Publication number: 20080153845
    Abstract: The present invention is directed to the use of TRPV1 antagonists as inhibitors of certain taste perceptions and functions. The invention is also directed to, among other things, compositions comprising the TRPV1 antagonists that can be used in pharmaceutical, food, and other products to inhibit certain taste functions and perceptions.
    Type: Application
    Filed: October 29, 2007
    Publication date: June 26, 2008
    Applicant: REDPOINT BIO CORPORATION
    Inventors: R. Kyle PALMER, Daniel Long, Heather Devantier, S. Paul Lee, M.N. Tulu Buber, Robert Bryant
  • Publication number: 20080124753
    Abstract: The present invention is related to a screening method to identify compounds that impact taste. Reactivity profiles of spice compounds are determined by assaying activity in test cells expressing various ion channels. The reactivity profiles can be used to identify novel taste compounds having similar taste effects.
    Type: Application
    Filed: November 15, 2007
    Publication date: May 29, 2008
    Inventors: Seunghun Paul LEE, M.N. Tulu BUBER, Ivona BAKAJ, Robert W. BRYANT